M&A Science

Roy Schoenberg, President & Co-CEO at Amwell - American Well Corporation (NYSE:AMWL) The healthcare industry is a complex and rigid space where change is often rejected. Any evolution in this sector not only signifies business decisions but also influences the overall quality and accessibility of patient care.  In this episode of the M&A Science Podcast, Roy Schoenberg, President & Co-CEO at Amwell, delves into the intricacies of navigating M&A in the healthcare industry. ____________________________________________________________________________ This episode is sponsored by the M&A Science Academy, DealRoom, and FirmRoom.  To join our growing online community of M&A practitioners, visit www.mascience.com/academy.  Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at www.dealroom.net. FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to www.firmroom.com. Episode Timestamps 00:00 Intro 04:26 Evolving from a medical background to M&A 07:27 What makes the healthcare space distinct 09:36 What drove Amwell to do acquisitions 13:03 Shaping the acquisition strategy 16:59 Amwell’s first acquisition 22:29 Integrating the new company 24:50 Retaining key people 28:33 First acquisition lessons learned 31:03 Dealing with transaction surprises 34:03 Approaching deals as one of the main principal 38:01 Deal sourcing 39:49 Managing relationships with the counterparty 41:30 Communication during diligence 43:14 Craziest thing in M&A  

Mark Rayfield, CEO of Saint-Gobain North America and CertainTeed, discusses the importance of culture in M&A, challenges faced during integration, strategies for successful integration, measuring success metrics, and integrating cultures in non-core acquisitions.

Dr. Irit Yaniv, Founding Partner and CEO at Almeda Ventures (TLV: AMDA) While most investors have a passive role in their portfolio company, some investors are active in shaping and contributing to its success. For venture capitalists, one of the best scenarios is for the portfolio company to be acquired to maximize investment returns.  In this episode of the M&A Science Podcast, Dr. Irit Yaniv, Founding Partner and CEO at Almada Ventures, discusses what investors can do when planning and executing the exit. ____________________________________________________________________________ This episode is sponsored by FirmRoom, the fastest virtual data room used to get deals done. FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to www.firmroom.com  Episode Timestamps 00:00 Intro 03:26 M&A in the medical device industry 04:49 Minority position during Investment 05:35 When to think about an exit 06:59 Getting involved in the exit  09:57 Working with the CEO 12:03 Keeping track of potential acquisitions 14:34 Finding the right buyer 17:55 Managing exit planning disagreements 20:34 Who controls exit decisions 22:23 Negotiation 25:37 When to engage with a banker 36:51 Advice on planning an exit 38:11 Bad exits 40:29 Other takeaways 42:35 Craziest thing in M&A

Barak Routhenstein, VP of Corporate Development at Profile Products, discusses changes in M&A landscape, private equity acquisitions, deal origination, managing underperforming companies, and the ideal relationship between E-sponsor and P-E sponsor in portfolio company acquisitions.

Glenn Sanford, CEO eXp World Holdings, Inc. (NASDAQ: EXPI) For high-growth companies, M&A is almost inevitable. If done right, it could speed up growth and open new opportunities for the acquiring entity. However, it’s not without challenges, as it can also be destructive and destroy both companies involved.  In this episode of the M&A Science Podcast, Glenn Sanford, CEO eXp World Holdings, Inc., discusses the art of M&A, and striking the right balance between integration and autonomy. ____________________________________________________________________________ Join us on October 5th, 2023, in New York City for the  M&A Science Fair 2023. Dive into a transformative M&A experience that not only emphasizes participant-driven topics but also offers an unparalleled opportunity to network with the industry's top minds. You can elevate your M&A practice with actionable insights and top-tier networking. The event is invitation-only to ensure a curated experience. Secure your invite today! Episode Timestamps 00:00 Intro 03:51 EXP’s acquisition history 05:31 Reasons behind EXP’s acquisitions 10:12 Acquiring Success Magazine 14:22 Factors to consider when looking at potential targets 17:49 Understanding a company’s culture 20:13 Reverse merger 24:38 Capital structure evolution 27:05 Managing relationships with the board of directors and shareholders 31:19 Managing integration 36:47 Other lessons and takeaways 39:03 Craziest thing in M&A  

Andrew Bilbao, current CFO of Noble Education Acquisition Corp.  M&A is a massive undertaking that calls for collaboration among numerous individuals. Ensuring alignment with everyone involved is essential for the success of a deal. Yet, with a variety of opinions and personalities at play, achieving alignment can be quite a challenge.  In this episode of the M&A Science Podcast, Andrew Bilbao, CFO of Noble Education Acquisition Corp, shares valuable insights on how to guarantee alignment for deal success, paving the way for a smooth and fruitful M&A process. ____________________________________________________________________________ Join us on October 5th, 2023, in New York City for the  M&A Science Fair 2023. Dive into a transformative M&A experience that not only emphasizes participant-driven topics but also offers an unparalleled opportunity to network with the industry's top minds. You can elevate your M&A practice with actionable insights and top-tier networking. The event is invitation-only to ensure a curated experience. Secure your invite today! Episode Timestamps 00:00 Intro 04:47 Areas where alignment is important 07:03 Approach to Alignment 11:19 Prioritizing the pipeline 14:11 Identifying an opportunity to LOI 15:56 Target Market Competitiveness 19:50 Evolving from first conversations 20:59 Go/No-go decision 25:47 Bidding process 28:45 Things to not do when dealing with the Board 29:55 Working with functional leads 33:41 Alignment with functional leads 35:53 Keeping alignment to strategy 38:16 The hardest part of achieving alignment 39:10 How do you not fall in love with your deal? 46:41 Craziest thing in M&A  

Greg Stein, VP of M&A at Xerox, discusses transitioning from public equity analyst to executing M&A, the impact of deal announcements on stock price, evaluating and acquiring a business, and negotiations and strategies.

Clifford Felig, Partner at Meitar | Law Offices, discusses the challenges of cross-border deals. Topics include finding attorneys, time differences, local laws, nature of deals in Isreal, negotiating differences, and the importance of attorney's experience.

Lesley Adamo, Vice Chair of the Tax Group at Lowenstein Sandler LLP, discusses tax complexities in M&A deals, minimizing risks, stock vs. asset sales, net operating losses, creating a holding company, efficient tax structuring, considerations during negotiations and LOI, qualified small business stock, relocation for tax savings, and tax considerations during diligence.

Juan Guillermo Castaneda, former Senior Advisor to SKG CEO (LSEG: SKG) This episode is sponsored by the M&A Science Academy, DealRoom, and FirmRoom. To join our growing online community of M&A practitioners, visit www.mascience.com/academy.  Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at https://www.dealroom.net. FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to www.firmroom.com Episode Timestamps: 00:00 Intro 04:13 Difference of M&A in the US vs Latin America 10:14 Mitigating Risks 14:31 Culture 17:54 Deal sourcing 19:41 Approaching companies 21:02 Getting companies interested 22:46 Dealing with Legacies 25:06 Red Flags in deals 29:59 Integration 33:11 Alignment before closing 34:01 Lessons Learned 35:37 Negotiations 36:27 Craziest thing in M&A